Ziprax 200 DT Tablet contains Cefixime 200mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. This formulation is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, pharyngitis, tonsillitis, and uncomplicated gonorrhea caused by susceptible strains of bacteria. Ziprax 200 DT is designed as a dispersible tablet, facilitating ease of administration, especially in pediatric and geriatric patients who may have difficulty swallowing conventional tablets. The drug exhibits good oral bioavailability and is primarily excreted unchanged via the kidneys. Dosage and duration of therapy should be determined based on the severity of infection, patient age, and renal function. Common adverse effects include gastrointestinal disturbances such as diarrhea, nausea, abdominal pain, and allergic reactions like rash or pruritus. Caution is advised in patients with a history of hypersensitivity to cephalosporins or penicillins. Use during pregnancy and lactation should be under medical supervision. It is essential to complete the full prescribed course to prevent the development of resistant bacterial strains. Ziprax 200 DT should be stored in a cool, dry place away from direct sunlight.